Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Deconinck

Showing results (21-30 of 236) with videos related to

Pageof 24
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 31, 2018
Falsification of biotechnology drugs: current dangers and/or future disasters?Steven Janvier, Bart De Spiegeleer, Celine Vanhee, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 5, 2012
Modelling aluminium leaching into food from different foodware materials with multi-level factorial design of experimentsVeronika Fekete, Eric Deconinck, Fabien Bolle, et al.
Drug Testing and Analysis|August 28, 2019
Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in BelgiumYaxin Tie, Kevin van Loock, Eric Deconinck, et al.
Drug Testing and Analysis|October 4, 2023
Characterization of CBD oils, seized on the Belgian market, using infrared spectroscopy: Matrix identification and CBD determination, a proof of conceptCéline Duchateau, Caroline Stévigny, Kris De Braekeleer, et al.
Drug Testing and Analysis|October 21, 2022
Response to letter to the editor: "Comments on 'discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers'"Eric Deconinck, Michaël Canfyn, Céline Duchateau, et al.
Archives of Toxicology|July 6, 2023
Applicability of the DPRA on mixture testing: challenges and opportunitiesQuinten Marcelis, Eric Deconinck, Vera Rogiers, et al.
JCO Oncology Practice|August 18, 2020
Pyogenic Granuloma During Ibrutinib Therapy for B-Cell NeoplasiaXavier Roussel, Romain Charollais, Eric Deconinck, et al.
Journal of Pharmaceutical Analysis|February 7, 2018
A simple dilute and shoot methodology for the identification and quantification of illegal insulinCeline Vanhee, Steven Janvier, Goedele Moens, et al.
Pharmacoeconomics|December 18, 2009
Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluationEric Deconinck, Houda Miadi-Fargier, Claude Le Pen, et al.
Journal of Chemical Information and Modeling|May 23, 2006
Classification tree models for the prediction of blood-brain barrier passage of drugsEric Deconinck, Menghui H Zhang, Danny Coomans, et al.
Pageof 24

Showing results (21-30 of 236) with videos related to

Sort By:
Pageof 24
Journal of Pharmaceutical and Biomedical Analysis|August 31, 2018
Falsification of biotechnology drugs: current dangers and/or future disasters?Steven Janvier, Bart De Spiegeleer, Celine Vanhee, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|June 5, 2012
Modelling aluminium leaching into food from different foodware materials with multi-level factorial design of experimentsVeronika Fekete, Eric Deconinck, Fabien Bolle, et al.
Drug Testing and Analysis|August 28, 2019
Evaluation of impurities and dissolution profiles of illegal antimicrobial drugs encountered in BelgiumYaxin Tie, Kevin van Loock, Eric Deconinck, et al.
Drug Testing and Analysis|October 4, 2023
Characterization of CBD oils, seized on the Belgian market, using infrared spectroscopy: Matrix identification and CBD determination, a proof of conceptCéline Duchateau, Caroline Stévigny, Kris De Braekeleer, et al.
Drug Testing and Analysis|October 21, 2022
Response to letter to the editor: "Comments on 'discrepancies between validated GC-FID and UHPLC-DAD methods for the analysis of Δ-9-THC and CBD in dried hemp flowers'"Eric Deconinck, Michaël Canfyn, Céline Duchateau, et al.
Archives of Toxicology|July 6, 2023
Applicability of the DPRA on mixture testing: challenges and opportunitiesQuinten Marcelis, Eric Deconinck, Vera Rogiers, et al.
JCO Oncology Practice|August 18, 2020
Pyogenic Granuloma During Ibrutinib Therapy for B-Cell NeoplasiaXavier Roussel, Romain Charollais, Eric Deconinck, et al.
Journal of Pharmaceutical Analysis|February 7, 2018
A simple dilute and shoot methodology for the identification and quantification of illegal insulinCeline Vanhee, Steven Janvier, Goedele Moens, et al.
Pharmacoeconomics|December 18, 2009
Cost effectiveness of rituximab maintenance therapy in follicular lymphoma: long-term economic evaluationEric Deconinck, Houda Miadi-Fargier, Claude Le Pen, et al.
Journal of Chemical Information and Modeling|May 23, 2006
Classification tree models for the prediction of blood-brain barrier passage of drugsEric Deconinck, Menghui H Zhang, Danny Coomans, et al.
Pageof 24